Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharma | Vienna | Salute | Ricerca medica e biotecnologica | 118,27 Mrd € | -240,1x | 2,04 | 461,55 € | 2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regeneron Pharma | Vienna | Salute | Ricerca medica e biotecnologica | 73,47 Mrd € | 18,1x | 1,67 | 686,20 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
argenx SE | Vienna | Salute | Ricerca medica e biotecnologica | 31,50 Mrd € | 40,6x | 0,13 | 529,40 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
IQVIA Holdings | Vienna | Salute | Ricerca medica e biotecnologica | 30,66 Mrd € | 25,2x | 8,97 | 177,85 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BioNTech SE DRC | Vienna | Salute | Ricerca medica e biotecnologica | 23,27 Mrd € | -36,2x | 0,44 | 94,75 € | -3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Moderna | Vienna | Salute | Ricerca medica e biotecnologica | 12,78 Mrd € | -3,9x | -0,16 | 33,52 € | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genmab AS | Vienna | Salute | Ricerca medica e biotecnologica | 12,06 Mrd € | 11,6x | 0,16 | 220,50 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Qiagen | Vienna | Salute | Ricerca medica e biotecnologica | 7,88 Mrd € | 106,7x | -1,34 | 36,57 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Galapagos NV | Vienna | Salute | Ricerca medica e biotecnologica | 1,57 Mrd € | 21,3x | 19,33 | 23,98 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novavax | Vienna | Salute | Ricerca medica e biotecnologica | 1,21 Mrd € | -6,7x | -0,09 | 7,76 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Evotec | Vienna | Salute | Ricerca medica e biotecnologica | 1,14 Mrd € | -6,6x | 0,09 | 6,36 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CureVac NV | Vienna | Salute | Ricerca medica e biotecnologica | 603,65 Mln € | -2,2x | -0,14 | 2,77 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Valneva | Vienna | Salute | Ricerca medica e biotecnologica | 523,16 Mln € | -60,1x | -0,78 | 3,27 € | -4,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medigene | Vienna | Salute | Ricerca medica e biotecnologica | 24,17 Mln € | -1,3x | -0,03 | 1,62 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |